week-old male Sprague-Dawley rats were purchased from a commercial ylprednisolone and a broad-spectrum matrix metalloproteinase invendor. The animals were divided into three groups: (1 ) the control hibitor (GM6001) did not develop emphysema. We conclude that group (n ϭ 6), (2 ) the methylprednisolone-treated group (n ϭ 8), and systemic treatment of adult rats with the antiinflammatory steroid (3 ) the methylprednisolone ϩ matrix metalloproteinase inhibitormethylprednisolone increases the activity of matrix metalloproteintreated group (n ϭ 6). The methylprednisolone-treated groups were ases in the lung and causes emphysema.
emphysematous lung parenchyma destruction (1) . Although hol). The control animals were injected with deionized water. chronic inhalation of tobacco smoke is by far the most common cause of chronic obstructive lung disorders and chronic Tissue Processing tobacco smoke exposure of mice (2) and guinea pigs (3) has After completion of the treatment period, rats were anesthetized with been shown to cause emphysema, a number of genetic animal ketamine (60 mg/kg) and xylazine (8 mg/kg) intramuscularly. The chest models have recently been developed that allow the examinawas opened and lung and heart were quickly isolated and excised. The tion of mechanisms of lung parenchyma destruction in the left lung was inflated with 0.5% low melting agarose at the constant absence of chronic tobacco smoke exposure (4-7). For exampressure of 25 cm H 2 O and fixed in 10% formalin (16). Paraffin-embedple, we demonstrated recently that chronic vascular endotheded tissues were sectioned for histologic analysis.
lial growth factor receptor inhibition causes alveolar septal cell apoptosis, loss of lung capillaries, and emphysema both Lung Tissue Homogenates in neonatal (8) and adult rats (9) . Because more frequently
The right main bronchus was resected, and the right lung was homogesteroids are used for the treatment of the so-called exacerbanized immediately after harvest in a buffer containing 50 mM N-2-tions of chronic obstructive pulmonary disease (10-12) and hydroxyethylpiperazine-NЈ-ethane sulfonic acid, 1 mM dithiothreitol, because it has been reported that steroids can affect or modu-0.1% Triton X-100, and 10% glycerol. The homogenates were centrifuged at 10,000 ϫ g for 15 minutes, and supernatants were stored at Ϫ80ЊC until they were used. wall distance, was measured by light microscopy at a magnification of
Morphometry
Correspondence and requests for reprints should be addressed to Norbert F. Cruz, CA) were used. Immunolocalization was performed on paraffinZymography embedded rat lung tissue sections. After deparaffinization, the sections Zymography was performed using 10% Tris-glycine gels containing were rehydrated and submitted to microwave treatment (800 W/15 0.1% gelatin (Invitrogen Life Technologies Inc., Carlsbad, CA). Twenty minutes) in 10 mM citric monohydrate solution. After quenching of micrograms of lung extract protein were loaded per well, and gels were endogenous peroxidase with 3% hydrogen peroxide, the sections were electrophoresed. Gels were washed with 2.5% Triton X-100 for 30 exposed to anti-proliferating cell nuclear antigen antibodies (1:50) or minutes and subsequently incubated in 50 mM Tris-hydrogen chloride, anti-matrix metalloproteinase-9 antibodies (1:200). Then immunodecontaining 6.7 mM calcium chloride, 200 mM sodium chloride, and tection was performed using a biotinylated secondary antibody (Vec-0.02% Brij 35 at 37ЊC for 12 to 24 hours. The gels were stained with Coomassie brilliant blue and destained.
tor Laboratories, Burlingame, CA). Peroxidase-conjugated streptavidin with diaminobenzidine completed the stain. Negative controls for nonImmunohistochemistry specific binding included normal rat serum. Anti-proliferating cell nuclear antigen antibodies and anti-matrix metalloproteinase-9 antibodies (Santa Cruz Biotechnology, Inc., Santa
Immunofluorescence Staining for Localization of the Matrix Metalloproteinase-9
After deparaffinization, the rat lung tissue sections were rehydrated and steamed in BORG decloaker for 45 minutes. The sections were exposed to anti-matrix metalloproteinase-9 antibodies (1:200) and antiFactor VIII antibodies (1:800; DAKO Corporation, Carpinteria, CA) overnight at room temperature. Then the sections were blocked with normal horse serum and exposed to anti-goat and anti-rabbit fluorescent antibodies (1:200; Molecular Probes, Inc., Eugene, OR). 4Ј,6-diamidino-2-phenylindole dihydrochloride-containing mounting media was used.
Statistical Analysis
All the data are expressed as mean Ϯ SEM. Statistical analysis was performed with SPSS for Windows software package (SPSS Inc., Chicago, IL). The differences between groups were compared using one- Statistical difference was accepted at p values less than 0.05. 
RESULTS
could already be noted after 1 week of treatment ( Figure 2 ).
Morphometry
Treatment with the nonspecific matrix metalloproteinase inCompared with adult control rat lungs, methylprednisolonehibitor (GM6001) prevented the increase in the mean linear treated rat lungs had enlarged airspaces. The mean linear interintercept and the decrease in the surface-volume ratio in methylcept, interalveolar wall distance, in the methylprednisolone-treated prednisolone-treated rats (Figure 1 ). group was greater than that in the control group Relative density of the zymogram showing gelatinolytic activity. Methylprednisolone-treated rat lungs have increased matrix metalloprotenase-9 activity compared with the control rat lungs. Lungs from rats treated with methylprednisolone and GM6001 showed a decreased MMP-9 activity. CTL ϭ control; MMP-2 ϭ matrix metalloproteinase-2; MMP-9 ϭ matrix metalloproteinase-9; MP ϭ methylprednisolone. *p Values less than 0.05 compared with control and MP ϩ GM6001 groups for MMP-9. prednisolone-treated animals, and lungs from methylpredniso-
Immunohistochemistry and Immunofluorescence for
lone ϩ GM6001-treated animals (Figure 3 ), indicating that methyl-
Matrix Metalloproteinase-9
prednisolone did not inhibit lung cell growth.
The immunohistochemistry for matrix metalloproteinase-9 showed endothelial cell location of matrix metalloproteinase-9 in control Zymography animals and in methylprednisolone-treated rat lungs expansion In the gelatin zymogram, methylprednisolone-treated rat lung exof the staining pattern to alveolar septal cells. The expression tracts demonstrated a significant increase in matrix metalloproof matrix metalloproteinase-9 in the lungs from GM6001-treated teinase-9 activities when compared with control lungs. Treatanimals resembled that observed in the animals not treated with ment with GM6001 reduced the lung tissue activity of the matrix methylprednisolone ( Figures 6 and 7) . metalloproteinase-9 ( Figure 4 ). Figure 5 shows that an increase in the matrix metalloproteinase-9 activity already occurred after DISCUSSION 2 weeks of steroid treatment. Matrix metalloproteinase-2 activity was also detected in the lung tissue extract, but there was no dif-
The data presented here demonstrate that treatment of adult rats for 1, 2, and 4 weeks with methylprednisolone causes pulmonary ference of matrix metalloproteinase-2 activity in the lungs from the three animal groups.
emphysema. Because the immunohistochemistry for proliferat- In control rat lungs, MMP-9 was confined to endothelial cells of the small vessels, whereas in the lungs from methylprednisolone-treated rats MMP-9 was expressed not only in the endothelial cells in the vessels but also in the alveolar septal cells (arrows). Treatment of GM6001 decreased the expression of MMP-9 in alveolar septal cells to the levels comparable with the control rat lungs.
ing cell nuclear antigen showed no difference in the number of proWe treated rats with a high dose of methylprednisolone (2 mg/ liferating cell nuclear antigen-positive cells between untreated kg), as is common in the treatment of patients with exacerbations and methylprednisolone-treated rats, it is unlikely that the steof chronic obstructive pulmonary disease (20) . roid treatment did inhibit lung cell growth. The gelatin zymogram However, the implications of our animal data for the treatof lung tissues from methylprednisolone-treated rats showed an ment of human disease are not clear at present. The natural increase in the activity of matrix metalloproteinase-9 after 2 and 4 history of chronic obstructive pulmonary disease is incompletely weeks of methylprednisolone treatment. The immunohistochemunderstood and different phenotypes of patients with chronic istry showed that matrix metalloproteinase-9 was principally loobstructive pulmonary disease may respond differently to varicalized to vascular endothelial cells, however, methylprednisolone ous drugs. treatment caused matrix metalloproteinase-9 expression also in Our animal model is of interest as a proof of concept in the alveolar septal cells, which was prevented by the broad-spectrum context of the protease/antiprotease hypothesis of emphysema matrix metalloproteinase inhibitor GM6001.
(2, 21), and because of the observation of increased expression Glucocorticoids have been shown to decrease the amount of of gelatinase and collagenases in the lungs from patients with matrix metalloproteinase-9 protein in sputum samples (14) and chronic obstructive pulmonary disease (22), and the demonstrathe expression of matrix metalloproteinase-9 in bronchial epithetion of the release of matrix metalloproteinase-9 by alveolar lium (13) of patients with asthma. Directionally, these findings are macrophages from patients with chronic obstructive pulmonary different from our results because we demonstrate that methyldisease (23). Although it had been previously recognized that gluprednisolone treatment increases the number of cells that express cocorticoids can affect the alveolarization in animal experiments matrix metalloproteinase-9. Apparently, there are species-and (24-27), our finding that glucocorticoid treatment increases the cell-specific differences in the response of matrix metalloproactivity of a gelatinase in the lung tissue provides new mechanisteinases to steroids-for example, it has been shown that rat and tic information. Our observation that a broad-spectrum inhibitor human vascular smooth muscle cells responded differently to of metalloproteinases (GM6001) prevented the methylprednidexamethasone with regard to cell migration and matrix metalloproteinase-2 activity (19) .
solone-induced emphysema in the adult rats indicates that pro-exacerbations of chronic obstructive pulmonary disease. N Engl J Med teolytic processes are indeed involved in the lung parenchyma 1999;340:1941-1947. destruction in this particular model. The precise cellular and mo- 
